Hepatitis B virus and hepatocellular carcinoma--treatment of HBV carriers with Phyllanthus amarus Extracts of Phyllanthus amarus inhibit the DNA polymerase of HBV and related viruses. Woodchuck carriers of woodchuck hepatitis virus (WHV) were treated in... BS Blumberg,I Millman,PS Venkateswaran,......
Mohandas KM: Hepatitis B associated hepatocellular carcinoma: epidemiology, diagnosis and treatment. Hep B Annual 2004; 1: 140 - 152.Mohandas KM (2004) Hepatitis B associated hepatocellu- lar carcinoma: epidemiology, diagnosis and treatment. Hepatitis B Annual 1: 140-152....
In this study, we assessed apoptosis in the hepatocellular carcinoma (HCC) cell line HepG2 induced by an injectable extract from the seed of MethodsInjectable SC was applied to HepG2 cells at different concentrations and the cells were collected 12, 24 and 48 hours later. 5-fluorouracil was...
We conclude that HSP expression in HepG2 cells can be enhanced by heat shock treatment in vitro. We suggest that this mechanism can be exploited in increasing tumor immunogenicity. 展开 关键词: Carcinoma, Hepatocellular Heat-Shock Proteins 70 Heat-Shock Proteins 90 癌, 肝细胞 热休克蛋白质类70...
Hepatocellular carcinoma (HCC) is a common type of tumor worldwide. The development of systemic treatment of advanced HCC has remained stagnant for a considerable period. During the last years, a series of new treatment regimens based on the combination of immunotherapeutic drugs and targeted drugs...
: Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 1998, 129:643–653. PubMed CAS Google Scholar Nagao T, Inoue S, Gotos S, et al.: Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann...
The first study demonstrating survival benefit in second-line treatment for patients with advanced HCC progressing to sorafenib therapy. CAS PubMed Google Scholar Abou-Alfa, G. K. et al. Cabozantinib in patients with advanced and progressing hepatocellular carcinoma. N. Engl. J. Med. 379, 54...
Hepatocellular carcinoma (HCC) is the fifth most common cause of cancer, and its incidence is increasing worldwide because of the dissemination of hepatitis B and C virus infection. Patients with cirrhosis are at the highest risk and should be monitored every 6 months. Surveillance can lead to ...
Although immunization can protect individuals from being infected by the hepatitis B virus, the early detection of HCC in those who have been infected by the virus remains a challenge. Thus most HCCs present late and are not suitable for curative treatment. Hence there is a tremendous interest ...
Hepatocellular Carcinoma‐associated Protein TD26 Interacts and Enhances SREBP1 Activity to Promote Tumor Cell Proliferation and Growth A system including Global Positioning Systems (GPS) and digital cartography is a good solution to carry out vehicle's guidance. However, it has inconvenien... C Wang...